Transjugular Intrahepatic Portosystemic Shunt for Patients With Portal Hypertension: an Observational, Cohort Study
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Cirrhosis Portal
- Sponsor
- Nanfang Hospital, Southern Medical University
- Enrollment
- 300
- Locations
- 1
- Primary Endpoint
- TIPS shunt dysfunction
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
This is a single-center, prospective, observational study intended to include patients receiving TIPS for portal hypertension. Baseline data of enrolled patients were recorded, and samples of ascites, feces and urine were collected before surgery. Venous blood (superior mesenteric vein, hepatic vein, peripheral vein) from different parts of the entero-hepatic axis was retained during operation, and patients were followed up regularly for 2 years. The incidence of infection, hepatic encephalopathy, upper gastrointestinal hemorrhage and ascites in patients with portal hypertension who received TIPS intervention were observed within 3 months after operation. And the stent patency was observed within 2 years after surgery. To investigate the characteristics of microbial, protein and metabolic components on enterohepatic axis and their relationship with prognosis of patients with cirrhosis by detecting microbiome, proteome and metabolome.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients undergoing TIPS due to complications related to portal hypertension；
- •Age between 18 to 85 years;
- •Signed informed consent;
Exclusion Criteria
- •Combined with liver cancer (out of the Milan criteria) or combined with other organ malignancies which had less than 3 months of expected survival;
- •Combined with severe cardiopulmonary disease (severe pulmonary hypertension and heart failure or severe heart valve insufficiency or renal insufficiency), the expected survival is less than 3 months;
- •Failure of TIPS procedure;
- •Women who plan to become pregnant or who are pregnant or breastfeeding；
- •Conditions deemed unsuitable for study participation by the investigator.
Outcomes
Primary Outcomes
TIPS shunt dysfunction
Time Frame: two years
Secondary Outcomes
- death(2 years)
- liver transplant(2 years)